PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Bioscience, College of Life and Environmental Sciences, University of Exeter, Stocker Road, Exeter, EX4 4QD, UK. andrew.m.shaw@exeter.ac.uk and Attomarker Ltd, Innovation Centre, University of Exeter, Rennes Drive, Exeter, EX4 4RN, UK.\', \'Exeter Test Group, College of Medicine and Health, University of Exeter, St Luke\'s Campus, Heavitree Road, Exeter, EX1 2LU, UK.\', \'Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy\'s and St Thomas\' NHS Foundation Trust, London SE1 7EH, UK. Jonathan.Edgeworth@gstt.nhs.uk.\', \'Attomarker Ltd, Innovation Centre, University of Exeter, Rennes Drive, Exeter, EX4 4RN, UK.\', \'Department of Infectious Diseases, School of Immunology & Microbial Sciences, King\'s College London, UK.\', \'Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy\'s and St Thomas\' NHS Foundation Trust, London SE1 7EH, UK. Jonathan.Edgeworth@gstt.nhs.uk and Department of Infectious Diseases, School of Immunology & Microbial Sciences, King\'s College London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1039/d0an01066a
?:hasPublicationType
?:journal
  • The Analyst
is ?:pmid of
?:pmid
?:pmid
  • 32638712
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.249
?:rankingScore_hIndex
  • 129
is ?:relation_isRelatedTo_publication of
?:title
  • Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all